Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial

Annals of Internal Medicine

Volumn 125, Issue 12, 1996, Pages 961-968

  Buckley, Lenore M ^a   Leib, Edward S ^b   Cartularo, Kathryn S ^b   Vacek, Pamela M ^b   Cooper, Sheldon M ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CARBONATE; COLECALCIFEROL; GLUCOCORTICOID; PREDNISONE; CORTICOSTEROID; PLACEBO;

ADULT; AGED; ARTICLE; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FEMUR; HUMAN; LUMBAR VERTEBRA; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; BONE ATROPHY; BONE MINERAL; DOSE RESPONSE; LUMBAR SPINE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BONE DENSITY; CALCIUM CARBONATE; CHOLECALCIFEROL; DOUBLE-BLIND METHOD; FEMALE; FEMUR; FOOD, FORTIFIED; GLUCOCORTICOIDS; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; PREDNISONE;

EID: 0030304054     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-125-12-199612150-00004     Document Type: Article

References (52)

1. Rickers H, Deding A, Christiansen C, Rodbro P. Mineral loss in cortical and trabecular bone during high-dose prednisone treatment. Calcif Tissue Int. 1984;35:269-73.
2. Sambrook PN, Eisman JA, Yeates MG, Pocock NA, Eberl S, Champion GD. Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Ann Rheum Dis. 1986;45:950-3.
3. Laan RF, van Riel PL, van de Putte LB, van Erning U, van't Hof MA, Lemmens JA. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Ann Intern Med. 1993;119:963-8.
4. Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM. The effects of low dose corticosteroids on the bone mineral density of patients with rheumatoid arthritis. J Rheumatol. 1996;22:1055-9.
5. Hall GM, Spector TD, Griffin AJ, Jawad AS, Hall ML, Doyle DV. The effects of rheumatoid arthritis and steroid therapy on bone density in post-menopausal women. Arthritis Rheum. 1993;36:1510-6.
6. Garton MJ, Reid DM. Bone mineral density of the hip and of the antero-posterior and lateral dimensions of the spine in men with rheumatoid arthritis. Effects of low-dose corticosteroids. Arthritis Rheum. 1993;36:222-8.
7. Clegg DO, Egger MJ, Ward JR. Osteoporotic vertebral compression fractures in rheumatologic patients treated with prednisone. Arthritis Rheum. 1983;26(Suppl):S47.
8. Butler RC, Davie MW, Worsfold M, Sharp CA. Bone mineral content in patients with rheumatoid arthritis: relationship to low-dose steroid therapy. Br J Rheumatol. 1991;30:86-90.
9. Verstraeten A, Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in post-menopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis. 1986;45:852-7.
10. MacAdams MR, White RH, Chipps BE. Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med. 1986;104:648-51.
11. Sambrook PN, Eisman JA, Champion GD, Pocock NA. Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum. 1988;31:973-8.
12. Chyun YS, Kream BE, Raisz LG. Cortisol decreases bone formation by inhibiting periosteal cell proliferation. Endocrinology. 1984;114:447-80.
13. Canalis E. Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae. Endocrinology. 1983;112:931-9.
14. Aloia JF, Semla HM, Yeh JK. Discordant effects of glucocorticoids on active and passive transport of calcium in the rat duodenum. Calcif Tissue Int. 1984;36:327-31.
15. Kimberg DV, Baerg RD, Gershon E, Graudusius RT. Effect of cortisone treatment on active transport of calcium by the small intestine. J Clin Invest. 1971;50:1309-21.
16. Klein RG, Arnaud SB, Gallagher JC, DeLuca HF, Riggs BL. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest. 1977;60:253-9.
17. Lukert BP, Adams JS. Calcium and phosphorus homeostasis in man. Effect of corticosteroids. Arch Intern Med. 1976;136:1249-53.
18. Kukreja SC, Bowser EN, Hargis GK, Henderson WJ, Williams GA. Mechanism of glucocorticoid-induced osteopenia: role of parathyroid glands. Proc Soc Exp Biol Med. 1976;152:358-61.
19. Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH. Altered mineral metabolism in glucocorticoid-induced osteopenia: effect of 25-hydroxyvitamin D administration. J Clin Invest. 1979;64:655-65.
20. Dykman TR, Haralson KM, Gluch OS, Murphy WA, Teitelbaum SL, Hahn TJ, et al. Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum. 1984;27:1336-43.
21. Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, et al. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med. 1993;328:1747-52.
22. Chestnut CH 3d. Osteoporosis and its treatment [Editorial]. N Engl J Med. 1992;326:406-8.
23. Meunier PJ. Is steroid-induced osteoporosis preventable? [Editorial]. N Engl J Med. 1993;328:1781-2.
24. Hahn TJ, Hahn BH. Osteopenia in subjects with rheumatic diseases. Principles of diagnosis and therapy. Semin Arthritis Rheum. 1976;6:165-88
25. Adachi JD, Bensen WG, Bianchi F, Cividino A, Pillersdorf S, Sebaldt RJ, et al. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a three year follow-up. J Rheumatol. 1996;23:995-1000.
26. Healy JH, Paget SA, Williams-Russo P, Szatrowski TP, Spiera H, Mitnick H, et al. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica. Calcif Tissue Int. 1996;58:73-8.
27. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24.
28. Willet WC Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, et al. Reproducibility and validity of a semi-quantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51-65.
29. Kannel WB, Sorlie P. Some health benefits of physical activity. The Framingham Study. Arch Intern Med. 1979;139:857-61.
30. Ramey DR, Reynould JP, Fries JF. The Health Assessment Questionnaire 1992: status and review. Arthritis Care Res. 1992;5:119-29.
31. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA. 1949;140:659-62.
32. Reid IR, Evans MC Stapleton J. Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss. J Bone Miner Res. 1992,7:1221-5.
33. Larnach TA, Boyd SJ, Smart RC Butler SP, Rohl PG, Diamond TH. Reproducibility of lateral spine scans using dual energy X-ray absorptiometry. Calcif Tissue Int. 1992;51:225-8.
34. Zerwekh JE, Emkey RD, Harris ED Jr. Low-dose prednisone therapy in rheumatoid arthritis: effect on vitamin D metabolism. Arthritis Rheum. 1984;27:1050-2.
35. Hahn TJ, Halstead LR, Haddad JG Jr. Serum 25-hydroxyvitamin D concentrations in patients receiving chronic corticosteroid therapy. J Lab Clin Med. 1977;90:399-404.
36. Seeman E, Kumar R, Hunder GG, Scott M, Heath H 3d, Riggs BL. Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and chronic glucocorticoid excess. J Clin Invest. 1980;66:664-9.
37. Hahn TJ, Halstead LR, Baran DT. Effects of short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab. 1981;52:111-5.
38. Lukert BP, Johnson BE, Robinson RG. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res. 1992;7:1063-9.
39. Hall GM, Daniels M, Doyle DV, Specter TD. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis Rheum. 1994;37:1499-505.
40. Reid IR, Ames RW, Evans MC Gamble GD, Sharpe SJ. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med. 1993;328:460-4.
41. Dawson-Hughes B, Dallal GE, Krall EA, Sadowski U Sahyoun N, Tannenbaum S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med. 1990;323:878-83.
42. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med. 1991;325:544-50.
43. Lee AH, Mull RL, Keenan GF, Callegari PE, Dalinka MK, Eisen HJ, et al. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med. 1994;96:35-41.
44. Meys E, Fontanges E, Fourcade N, Thomasson A, Pouyet M, Delmas PD. Bone loss after orthotopic liver transplantation. Am J Med. 1994;97:445-50.
45. Silverman SL, Mason J, Greenwald M. Quality of life after osteoporotic vertebral fracture. Arthritis Rheum. 1993;36:5122.
46. Silverman SL. The clinical consequences of vertebral compression fracture. Bone. 1992;13(Suppl 2):S27-31.
47. Reid IR, Ibbertson HK. Calcium supplements in the prevention of steroid-induced osteoporosis. Am J Clin Nutr. 1986;44:287-90.
48. 3 and calcium: short- and long-term effects. Clin Endocrinol (Oxf). 1977;7(Suppl):183s-9s.
49. Ringe JD, Welzel D. Salmon calcitonin in the therapy of corticoid-induced osteoporosis. Eur J Clin Pharmacol. 1987;33:35-9.
50. Montemurro L, Schiraldi G, Fraioli P, Tosi G, Riboldi A, Rizzato G. Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients. Calof Tissue Int. 1991;49:71-6.
51. Struys A, Snelder AA, Mulder H. Cyclic etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis. Am J Med. 1995;99:235-42.
52. Adachi J, Cranney A, Goldsmith CH, Bensen WG, Bianchi F, Cividino A, et al. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss. J Rheumatol. 1994;21:1922-6,